Detalhe da pesquisa
1.
Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera.
Br J Haematol
; 189(2): 291-302, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31945802
2.
Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling human myelofibrosis.
Blood
; 132(19): 2053-2066, 2018 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30213875
3.
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis.
Blood
; 129(24): 3227-3236, 2017 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28351937
4.
A case report of systemic mastocytosis associated with multiple hematologic non-mast cell lineage diseases.
Hematol Oncol
; 37(2): 205-211, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30849188
5.
Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosis.
Am J Hematol
; 94(8): 845-852, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31056768
6.
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia.
Blood
; 123(10): 1552-5, 2014 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24371211
7.
Spectrum of ASXL1 mutations in primary myelofibrosis: prognostic impact of the ASXL1 p.G646Wfs*12 mutation.
Blood
; 133(26): 2802-2808, 2019 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31076447
8.
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.
Am J Hematol
; 91(9): 918-22, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27264006
9.
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group.
Am J Hematol
; 91(7): 681-6, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27037840
10.
The incidence and morphology of Monckeberg's medial calcification in banked vascular segments from a monocentric donor population.
Cell Tissue Bank
; 17(2): 219-23, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26757897
11.
Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms.
Am J Hematol
; 95(1): E23-E26, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31659782
12.
Genetic lesions disrupting calreticulin 3'-untranslated region in JAK2 mutation-negative polycythemia vera.
Am J Hematol
; 95(10): E263-E267, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32572989
13.
Dyskerin depletion increases VEGF mRNA internal ribosome entry site-mediated translation.
Nucleic Acids Res
; 41(17): 8308-18, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23821664
14.
A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells.
Carcinogenesis
; 35(10): 2314-20, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25123131
15.
The nucleolar size is associated to the methylation status of ribosomal DNA in breast carcinomas.
BMC Cancer
; 14: 361, 2014 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24884608
16.
Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patients.
Am J Hematol
; 89(8): E121-4, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24753125
17.
Clonal architecture of JAK2V617F mutated cells during treatment with ruxolitinib.
Hematol Oncol
; 36(1): 357-359, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28474777
18.
SnoRNA U50 levels are regulated by cell proliferation and rRNA transcription.
Int J Mol Sci
; 14(7): 14923-35, 2013 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23867608
19.
JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib.
Blood
; 125(21): 3352-3, 2015 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25999444
20.
A life-threatening ruxolitinib discontinuation syndrome.
Am J Hematol
; 92(8): 833-838, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28457008